Oman: Delays in second dose of Pfizer-BioNTech

editorial January 28, 2021

Less than a minute

Oman’s Ministry of Health said the second dose of the Pfizer-BioNTech coronavirus vaccine will be postponed due to a temporary delay in global deliveries.

However, individuals should still show up for their second dose appointments.

Comments

Source

Moderna sues Pfizer over COVID vaccine patent infringement

December 8, 2021

BioNTech, Pfizer say 3 vaccine doses neutralise Omicron variant

December 3, 2021

COVID: BioNTech says possible to adapt vaccine for Omicron quickly

November 30, 2021

COVID-19: Biontech to develop adapted vaccine for Omicron variant

October 26, 2021

Oman: Over 85% of target population has received at least one jab

September 20, 2021

Oman: 80% of target population has received at least one jab

August 9, 2021

Oman: Muscat temporarily suspends vaccination campaign

July 27, 2021

BioNTech aims to develop mRNA vaccine for malaria

July 25, 2021

Oman resumes COVID-19 vaccination campaign

July 23, 2021

Oman: Delays in second dose of Pfizer-BioNTech

Comments

editorial

Read Next

Moderna sues Pfizer over COVID vaccine patent infringement

BioNTech, Pfizer say 3 vaccine doses neutralise Omicron variant

COVID: BioNTech says possible to adapt vaccine for Omicron quickly

COVID-19: Biontech to develop adapted vaccine for Omicron variant

Oman: Over 85% of target population has received at least one jab

Oman: 80% of target population has received at least one jab

Oman: Muscat temporarily suspends vaccination campaign

BioNTech aims to develop mRNA vaccine for malaria

Oman resumes COVID-19 vaccination campaign

Oman to reopen vaccination slots for people aged 18 above

Moderna sues Pfizer over COVID vaccine patent infringement

BioNTech, Pfizer say 3 vaccine doses neutralise Omicron variant

COVID: BioNTech says possible to adapt vaccine for Omicron quickly

COVID-19: Biontech to develop adapted vaccine for Omicron variant

Oman: Over 85% of target population has received at least one jab

Oman: 80% of target population has received at least one jab

Oman: Muscat temporarily suspends vaccination campaign

BioNTech aims to develop mRNA vaccine for malaria

Oman resumes COVID-19 vaccination campaign

Oman to reopen vaccination slots for people aged 18 above

GI TEST6

GI TEST5

GI Test4

GI Test3

Comments

Read Next

Moderna sues Pfizer over COVID vaccine patent infringement

BioNTech, Pfizer say 3 vaccine doses neutralise Omicron variant

COVID: BioNTech says possible to adapt vaccine for Omicron quickly

COVID-19: Biontech to develop adapted vaccine for Omicron variant

Oman: Over 85% of target population has received at least one jab

Oman: 80% of target population has received at least one jab

Oman: Muscat temporarily suspends vaccination campaign

BioNTech aims to develop mRNA vaccine for malaria

Oman resumes COVID-19 vaccination campaign

Oman to reopen vaccination slots for people aged 18 above

Bahrain: COVID-19 vaccination certificate through BeAware app

Qatar Airways resumes flights to UAE

Related Articles

GI TEST6

GI TEST5

GI Test4

GI Test3